All Articles

Associations of cardiovascular-kidney-metabolic syndrome stage with trabecular bone score and bone mineral density

Semaglutide in MASH with F2-F3 fibrosis: a holistic perspective on the ESSENCE phase 3 trial

Novel insights into the purinergic P2X7 receptor signaling in obesity and cardiovascular-kidney-metabolic syndrome: a brief overview

Associations of estimated pulse wave velocity with cardiovascular-kidney-metabolic syndrome in U.S. adults: the role of sex and ethnicity (NHANES 1999-2018)

Bilirubin ameliorates metabolic dysregulation by targeting the HSP90β/SREBPs signaling axis to improve insulin resistance and mitigate ectopic lipid deposition

Evolving models of care in patients with metabolic dysfunction-associated steatotic liver disease, recognising its population burden and the impact of metabolic dysfunction on incident rates of hepatic and extrahepatic outcomes

NAFLD to MAFLD: collaboration, not confusion - rethinking the naming of fatty liver disease

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver transplantation and nonalcoholic steatohepatitis: the state of the art

Chronic obstructive pulmonary disease (COPD) and metabolic fatty liver syndromes: a dangerous but neglected liaison

The Fatty liver Index (FLI) 15 years later: a reappraisal

Precision medicine approaches in metabolic disorders and target organ damage: where are we now, and where are we going?